CD1a-mediated T-cell responses to lipid antigens have been identified as important players in skin inflammation in atopic dermatitis (AD), with both ex vivo and animal models indicating the importance of this antigen presentation pathway and its potential as a therapeutic target (1–6). The gene discussed is CD1A; the disease is Alzheimer disease.